EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) in hypertrophic obstructive cardiomyopathy

Shengxu Li, Xuanye Bi iD, Quanxu An, Yuhang Li, Yazhe Tang

PLOS One · 2025

DOI: 10.1371/journal.pone.0328032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Shengxu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, C…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Receptor for Advanced Glycation End Products, Glycation End Products, Advanced. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advanced glycation end products(AGEs)/RAGE(receptor for AGEs) play divergent roles in cardiovascular disease. Our study is to evaluate the correlation between AGEs/RAGE in circulation (soluble AGEs/RAGE, sAGEs/sRAGE) and in myocardium (mAGEs/mRAGE), and to explore their relationship with cardiac function and prognostic value in hypertrophic obstructive cardiomyopathy (HOCM).

Methods

78 HOCM patients under septal myectomy were recruited. The soluble and myocardial AGEs/RAGE levels were determined by a commercial available ELISA kit at the time of baseline examination. Strain analysis in HOCM patients derived from cardiac magnetic resonance feature tracking, including global/septal radial strains (GRS/SRS), circumferential strains(GCS/SCS), and longitudinal strains(GLS/SLS). Histological fibrosis was assessed through masson’s staining as collagen volume fraction (CVF). All patients were followed up for a composite endpoint for a median duration of 3.8 years. Results sAGEs/sRAGE were higher in HOCM patients than healthy controls(p = 0.025; p = 0.028). Log sRAGE was correlated with log mRAGE(r = 0.739, p < 0.01), CVF(r = −0.411, p < 0.01), GRS (r = 0.412, p < 0.01), GCS(r = 0.463, p < 0.01). Log mRAGE also showed a correlation with CVF(r = −0.439, p = 0.003), SRS (r = 0.4, p = 0.013) and SCS (r = 0.362, p = 0.03). Log mAGEs was correlated with log mRAGE(r = 0.376, p = 0.012). Multivariate COX analysis revealed that log sRAGE was a significant predictor for the occurrence of adverse events in HOCM patients(HR, 0.013; 95% CI, 0.001–0.313; p = 0.007).

Conclusions

Circulating RAGE appears to act as a protective biomarker, as it is associated with better prognosis after septal myectomy, reducing fibrosis and improving cardiac function in HOCM patients. It is plausible that higher circulating RAGE levels may be derived from higher expression levels in the myocardium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicReceptor for Advanced Glycation End ProductsGlycation End Products, AdvancedHumansMaleFemaleMiddle AgedMyocardiumAdultPrognosisBiomarkersFibrosisCase-Control StudiesAged

Substanzen

Receptor for Advanced Glycation End ProductsGlycation End Products, AdvancedBiomarkers

Autor:innen und Institutionen

  • Department of Plastic Surgery, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People's Hospital), Zhengzhou, China.
  • Department of Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Be…
  • Department of Cardiology, Henan Province Key Laboratory of Cardiac Injury and Repair, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

ORCID-Profile: Xuanye Bi

Zitieren

APA

Li, S., Bi, X., An, Q., Li, Y., & Tang, Y. (2025). The role of advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) in hypertrophic obstructive cardiomyopathy. PLOS One. https://doi.org/10.1371/journal.pone.0328032

Vancouver

Li S, Bi X, An Q, Li Y, Tang Y. The role of advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) in hypertrophic obstructive cardiomyopathy. PLOS One. 2025. doi:10.1371/journal.pone.0328032

BibTeX
@article{Li2025,
  author = {Li, Shengxu and Bi, Xuanye and An, Quanxu and Li, Yuhang and Tang, Yazhe},
  title = {The role of advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) in hypertrophic obstructive cardiomyopathy},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0328032}
}
Kostenlos starten →